Posts Tagged ‘patent expiration’

New patent expiration for Pfizer drug GEODON

Annual Drug Patent Expirations for GEODON Geodon is a drug marketed by Pfizer and Pfizer Inc and is included in three NDAs. It is available from seven suppliers. There are…
The post New patent expiration for Pfizer drug GEODON appeared first on DrugPat…


New patent expiration for Gilead drug RANEXA

Annual Drug Patent Expirations for RANEXA Ranexa is a drug marketed by Gilead and is included in one NDA. It is available from three suppliers. There are ten patents protecting…
The post New patent expiration for Gilead drug RANEXA appeared first on Dr…


New patent expiration for Pfizer drug GEODON

Annual Drug Patent Expirations for GEODON Geodon is a drug marketed by Pfizer and Pfizer Inc and is included in three NDAs. It is available from seven suppliers. There are…
The post New patent expiration for Pfizer drug GEODON appeared first on DrugPat…


New patent expiration for Pfizer Inc drug GEODON

Annual Drug Patent Expirations for GEODON Geodon is a drug marketed by Pfizer and Pfizer Inc and is included in three NDAs. It is available from seven suppliers. There are…
The post New patent expiration for Pfizer Inc drug GEODON appeared first on Dru…


Drug Patent Expirations for the Week of May 19, 2019

VESICARE (solifenacin succinate) Astellas Patent: 6,017,927 Expiration: May 19, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Dr…


Drug Patent Expirations for the Week of May 19, 2019

VESICARE (solifenacin succinate) Astellas Patent: 6,017,927 Expiration: May 19, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Dr…


New patent expiration for Astellas drug VESICARE

Annual Drug Patent Expirations for VESICARE Vesicare is a drug marketed by Astellas and is included in one NDA. It is available from five suppliers. There is one patent protecting…
The post New patent expiration for Astellas drug VESICARE appeared firs…


Drug Patent Expirations for the Week of May 19, 2019

VESICARE (solifenacin succinate) Astellas Patent: 6,017,927 Expiration: May 19, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Dr…


Patent delisted for Allergan drug SANCTURA XR

Annual Drug Patent Expirations for SANCTURA+XR Sanctura Xr is a drug marketed by Allergan and is included in one NDA. There are five patents protecting this drug and one Paragraph…
The post Patent delisted for Allergan drug SANCTURA XR appeared first o…


Patent delisted for Allergan drug SANCTURA XR

Annual Drug Patent Expirations for SANCTURA+XR Sanctura Xr is a drug marketed by Allergan and is included in one NDA. There are five patents protecting this drug and one Paragraph…
The post Patent delisted for Allergan drug SANCTURA XR appeared first o…


Do NOT follow this link or you will be banned from the site!